Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




At Least Twenty Genes Regulate Cellular Cholesterol Metabolism

By LabMedica International staff writers
Posted on 16 Jul 2009
Maintaining the proper level of cholesterol is critical to avoiding vascular lipid deposits that are the prelude to heart disease. More...
To manage this task cells utilize a panel of at least 20 enzymes.

To study how cells maintain their cholesterol balance at the molecular level investigators at the University of Heidelberg (Germany) first used genome-wide gene-expression profiling of sterol-depleted cells and systematic literature queries to identify candidate genes. To further refine the list of candidate genes they developed two microscopic assays that allowed them to observe how blocking individual genes with siRNA (small interfering RNA) affected cholesterol metabolism. One assay used the cholesterol-binding dye Filipin to visualize cellular cholesterol levels, while the other employed fluorescence-labeled LDL (low density lipoprotein) to show cellular internalization.

Results published in the July 8, 2009, issue of the journal Cell Metabolism revealed that 20 genes acted as functional regulators of cellular cholesterol homeostasis. Of these, the TMEM97 gene was identified as an SREBP (sterol regulatory element binding protein) target gene that under sterol-depleted conditions localized to lysosomal compartments and bound to the LDL cholesterol transport-regulating protein Niemann-Pick C1 (NPC1).

SREBPs are transcription factors that bind to the sterol regulatory element DNA sequence TCACNCCAC. When not activated, SREBPs are attached to the nuclear envelope and endoplasmic reticulum membranes. In cells with low levels of sterols, SREBPs are cleaved to a water-soluble N-terminal domain that migrates to the nucleus. These activated SREBPs then bind to specific sterol regulatory element DNA sequences and up regulate the synthesis of enzymes involved in sterol biosynthesis. Sterols in turn inhibit the cleavage of SREBPs, and therefore synthesis of additional sterols is reduced through a negative feed back loop.

"High cholesterol in the blood is considered to be responsible for excess cardiovascular morbidity and mortality," said Dr. Heiko Runz, professor of human genetics at the University of Heidelberg. "Blood cholesterol levels are controlled by cholesterol in cells. Therefore, some of the genes identified by us as regulators of cellular cholesterol in future studies might turn out to be disease genes that contribute to hypercholesterolemia in some cases. Moreover, the strategy we used could open a new avenue to identify risk factors for cardiovascular disease."

Related Links:

University of Heidelberg




New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.